Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Neuber

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Dermatology (Basel, Switzerland)|January 1, 1996
B-cell chronic lymphocytic leukemia associated with high serum IGE levels and pruriginous skin lesions: successful therapy with IFN-alpha 2b after failure on IFN-gammaK Neuber, B Berg-Drewniock, M Volkenandt, et al.
Acta Dermato-Venereologica|January 1, 1995
Low dose versus medium dose UV-A1 treatment in severe atopic eczemaL Kowalzick, A Kleinheinz, M Weichenthal, et al.
Cancer|October 24, 2000
Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphomaL M Heinzerling, M Urbanek, J O Funk, et al.
British Journal of Cancer|October 29, 1998
Risk and outcome in metastatic malignant melanoma patients receiving DTIC, cisplatin, BCNU and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha2aR Hoffmann, I Müller, K Neuber, et al.
British Journal of Cancer|March 1, 2002
Combination chemotherapy with or without s.c. IL-2 and IFN-alpha: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM)J Atzpodien, K Neuber, D Kamanabrou, et al.
Anti-Cancer Drugs|September 7, 1999
Heterogeneity of chemosensitivity of metastatic cutaneous melanomaI A Cree, M H Neale, N E Myatt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III studyM F Avril, S Aamdal, J J Grob, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Dermatology (Basel, Switzerland)|January 1, 1996
B-cell chronic lymphocytic leukemia associated with high serum IGE levels and pruriginous skin lesions: successful therapy with IFN-alpha 2b after failure on IFN-gammaK Neuber, B Berg-Drewniock, M Volkenandt, et al.
Acta Dermato-Venereologica|January 1, 1995
Low dose versus medium dose UV-A1 treatment in severe atopic eczemaL Kowalzick, A Kleinheinz, M Weichenthal, et al.
Cancer|October 24, 2000
Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphomaL M Heinzerling, M Urbanek, J O Funk, et al.
British Journal of Cancer|October 29, 1998
Risk and outcome in metastatic malignant melanoma patients receiving DTIC, cisplatin, BCNU and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha2aR Hoffmann, I Müller, K Neuber, et al.
British Journal of Cancer|March 1, 2002
Combination chemotherapy with or without s.c. IL-2 and IFN-alpha: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM)J Atzpodien, K Neuber, D Kamanabrou, et al.
Anti-Cancer Drugs|September 7, 1999
Heterogeneity of chemosensitivity of metastatic cutaneous melanomaI A Cree, M H Neale, N E Myatt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III studyM F Avril, S Aamdal, J J Grob, et al.
Pageof 5